IRBT · As filed with the SEC
Irobot cash flow statement, by quarter
The statement as Irobot presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.
Consolidated Statements of Cash Flows · USD thousands
| USD thousands | Q3 2025† 3 months ended Sep 27, 2025 | Q2 2025† 3 months ended Jun 28, 2025 | Q1 2025 3 months ended Mar 29, 2025 | Q4 2024† 3 months ended Dec 28, 2024 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Net loss | (21,526)† | (22,808)† | (87,273) | (77,108)† |
| Adjustments to reconcile net loss to net cash used in operating activities: | ||||
| Depreciation and amortization | 1,534† | 1,762† | 2,623 | 4,755† |
| Loss on equity investment | 1,172† | 394† | 0 | (745)† |
| Stock-based compensation | 3,854† | 3,762† | 5,314 | 6,539† |
| Provision for inventory excess and obsolescence | 325† | 631† | 384 | 1,689† |
| Change in fair value of term loan | (3,766)† | (23,278)† | 25,965 | 11,042† |
| Debt issuance costs expensed under fair value option | (16,828)† | 5,214† | 11,614 | 54† |
| Deferred income taxes, net | 4,367† | 0† | 292 | (1,740)† |
| Other | 1,488† | 1,474† | 1,638 | — |
| Changes in operating assets and liabilities — (use) source | ||||
| Accounts receivable | (1,079)† | (23,891)† | 20,156 | 49,195† |
| Inventory | (53,847)† | (20,250)† | 7,434 | 69,491† |
| Other assets | 115† | 2,565† | 3,135 | 6,368† |
| Accounts payable | 30,539† | 69,070† | (9,642) | (87,644)† |
| Accrued expenses and other liabilities | (11,550)† | (24,014)† | (8,100) | 12,440† |
| Net cash used in operating activities | (47,586)† | (30,157)† | (26,460) | (2,746)† |
| Cash flows from investing activities: | ||||
| Additions of property and equipment | 0† | 0† | 0 | 0† |
| Purchase of investments | 0† | (6)† | (8) | (80)† |
| Net cash provided by (used in) investing activities | 594† | (6)† | (8) | (80)† |
| Cash flows from financing activities: | ||||
| Proceeds from employee stock plans | — | — | — | 0† |
| Income tax withholding payment associated with restricted stock vesting | (114)† | (173)† | (84) | (16)† |
| Proceeds from issuance of common stock, net of issuance costs | 0† | 0† | 0 | (62)† |
| Repayment of term loan | 0† | — | — | 0† |
| Proceeds from term loan | — | — | — | 0† |
| Payment of debt issuance costs | — | — | — | (54)† |
| Net cash used in financing activities | (114)† | (4,173)† | (84) | (132)† |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | (58)† | 992† | 922 | (971)† |
| Net decrease in cash, cash equivalents and restricted cash | (47,164)† | (33,344)† | (25,630) | (3,929)† |
| Cash, cash equivalents and restricted cash, at beginning of period | 78,977 | 112,321 | 137,951 | 141,880 |
| Cash, cash equivalents and restricted cash, at end of period | 31,813 | 78,977 | 112,321 | 137,951 |
† Derived: worked out from the filings, not stated in them. A fourth quarter is the 10-K year less the nine months in the third-quarter 10-Q; a quarter of cash flows is year to date less the prior year to date.
As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.